These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 27618077)

  • 1. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.
    Zhang CM; Lv JF; Gong L; Yu LY; Chen XP; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27618077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability testing and its role in the management of colorectal cancer.
    Kawakami H; Zaanan A; Sinicrope FA
    Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.
    Stadler ZK
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):29-41. PubMed ID: 25475571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.
    Tsai CY; Lin TA; Huang SC; Hsu JT; Yeh CN; Chen TC; Chiu CT; Chen JS; Yeh TS
    Oncologist; 2020 Jul; 25(7):e1021-e1030. PubMed ID: 32058649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine.
    Gatalica Z; Vranic S; Xiu J; Swensen J; Reddy S
    Fam Cancer; 2016 Jul; 15(3):405-12. PubMed ID: 26875156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing.
    Ryan E; Sheahan K; Creavin B; Mohan HM; Winter DC
    Crit Rev Oncol Hematol; 2017 Aug; 116():38-57. PubMed ID: 28693799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.
    Copija A; Waniczek D; Witkoś A; Walkiewicz K; Nowakowska-Zajdel E
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.
    Sehdev A; Cramer HM; Ibrahim AA; Younger AE; O'Neil BH
    Discov Med; 2016 May; 21(117):341-7. PubMed ID: 27355330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.
    Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of MMR-deficient colorectal cancer.
    Devaud N; Gallinger S
    Fam Cancer; 2013 Jun; 12(2):301-6. PubMed ID: 23539382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MSI Status in Colorectal Cancer].
    Mishima S; Yoshino T
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1567-1572. PubMed ID: 30449839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of microsatellite stability status in colorectal cancer.
    Gupta R; Sinha S; Paul RN
    Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.
    Zaanan A; Meunier K; Sangar F; Fléjou JF; Praz F
    Cell Oncol (Dordr); 2011 Jun; 34(3):155-76. PubMed ID: 21484480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite Stable Colorectal Cancer With an Immunogenic Phenotype: Challenges in Diagnosis and Treatment.
    Saller J; Qin D; Felder S; Coppola D
    Clin Colorectal Cancer; 2020 Jun; 19(2):123-131. PubMed ID: 32171644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Microsatellite Instability Testing in Management of Colorectal Cancer.
    Sun BL
    Clin Colorectal Cancer; 2021 Mar; 20(1):e12-e20. PubMed ID: 32888812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
    Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.
    Quiroga D; Lyerly HK; Morse MA
    Curr Treat Options Oncol; 2016 Aug; 17(8):41. PubMed ID: 27315067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.